|
ZNF879 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.792400E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.415020E-01 |
| Normal-vs-Stage2 |
4.473900E-02 |
| Normal-vs-Stage3 |
7.81659999999906E-05 |
| Normal-vs-Stage4 |
8.92689999698604E-09 |
| Stage1-vs-Stage2 |
2.012400E-01 |
| Stage1-vs-Stage3 |
4.064400E-03 |
| Stage1-vs-Stage4 |
4.81960000020543E-07 |
| Stage2-vs-Stage3 |
4.572400E-01 |
| Stage2-vs-Stage4 |
4.033600E-02 |
| Stage3-vs-Stage4 |
5.468000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.399100E-04 |
| Normal-vs-AfricanAmerican |
6.600800E-03 |
| Normal-vs-Asian |
7.891600E-01 |
| Caucasian-vs-AfricanAmerican |
5.969800E-01 |
| Caucasian-vs-Asian |
4.801000E-01 |
| AfricanAmerican-vs-Asian |
3.466800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.160300E-04 |
| Normal-vs-Female |
8.303100E-03 |
| Male-vs-Female |
4.036400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.518180E-01 |
| Normal-vs-Age(41-60Yrs) |
2.875700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.86922999999561E-05 |
| Normal-vs-Age(81-100Yrs) |
8.674100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.017200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.701400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.426800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.037800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.327400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.838800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.436400E-01 |
| Normal-vs-Grade 2 |
7.272600E-01 |
| Normal-vs-Grade 3 |
1.58660000004751E-06 |
| Normal-vs-Grade 4 |
1.02740038698812E-11 |
| Grade 1-vs-Grade 2 |
4.405200E-01 |
| Grade 1-vs-Grade 3 |
1.268150E-02 |
| Grade 1-vs-Grade 4 |
2.21019999999683E-05 |
| Grade 2-vs-Grade 3 |
2.88559999994664E-06 |
| Grade 2-vs-Grade 4 |
8.15536527198901E-12 |
| Grade 3-vs-Grade 4 |
6.575600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.049800E-01 |
| Normal-vs-ccB subtype |
2.36099999995076E-07 |
| ccA subtype-vs-ccB subtype |
2.6314000001193E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.027760E-04 |
| Normal-vs-N1 |
1.59549999989572E-07 |
| N0-vs-N1 |
1.204240E-02 |
|
|
